SCEC research labs are experimenting and developing processes for scalable production of stem cell products. Laboratories from both Emory University and Georgia Tech are studying efficient and effective stem cell biomanufacturing procedures to treat immune disorders and diseases. The SCEC labs using bioprocessing and biomanufacturing techniques include:  
   
The Sambanis Laboratory is working towards developing enabling technologies for a living pancreatic substitute to treat insulin-dependent diabetes. Additionally, they are working to develop an efficacious and immune acceptable tissue substitute based on potentially autologous non-beta cells.

 
The Copland Laboratory is researching the molecular mechanisms that regulate the regenerative capacity of stem cells and progenitor cells. They are also interested in the therapeutic potential of mesenchymal stromal cells for immune disorders, therapeutic angiogenesis and cancer immunotherapy.